BCV Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.5M Sell
80,697
-2,226
-3% -$2.27M 3% 8
2026
Q1
$76.3M Buy
82,923
+983
+1% +$997K 2.62% 12
2025
Q4
$107M Buy
+81,940
New +$78.3M 2.69% 12

Other funds holding LLY

BCV Asset Management's LLY Position: Q2 2026 in Review

BCV Asset Management reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $2.27M and leaving 80,697 shares worth $99.5M. The position accounts for 3% of the portfolio, ranked #8.

BCV Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $107M in Q4 2025. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BCV Asset Management held 80,697 shares of Eli Lilly worth $99.5M as of Q2 2026.
  • BCV Asset Management sold 2,226 Eli Lilly shares in Q2 2026, an estimated $2.27M.
  • Eli Lilly made up 3% of BCV Asset Management's portfolio in Q2 2026, its #8 holding.
  • BCV Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • BCV Asset Management's Eli Lilly position peaked at $107M in Q4 2025.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BCV Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.